| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Business Operations | EVP, Biodefense Divison
1 company
Havey Adam is an EVP, Business Operations at Emergent BioSolutions Inc.. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sale+OE | 37,279 | $99.30 | $3,701,646.98 | -32.8% | |
| Apr 20, 2020 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sale+OE | 37,423 | $66.82 | $2,500,531.00 | -35.3% | |
| Apr 6, 2020 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sell | 7,972 | $60.00 | $478,320.00 | -9.9% | |
| Mar 11, 2019 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sell | 2,430 | $56.93 | $138,339.90 | -7.0% | |
| Mar 1, 2019 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sell | 3,043 | $58.11 | $176,819.11 | -4.1% | |
| Nov 2, 2018 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sale+OE | 8,179 | $64.25 | $525,534.50 | -12.3% | |
| Oct 17, 2018 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sale+OE | 314 | $61.50 | $19,311.00 | -1.1% | |
| Oct 16, 2018 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sale+OE | 22,996 | $61.06 | $1,404,025.96 | -13.5% | |
| Mar 12, 2018 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sell | 5,842 | $52.82 | $308,574.44 | -16.3% | |
| Mar 1, 2018 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sell | 1,898 | $49.50 | $93,951.00 | -5.4% |